Staphylococcus coagulase-positive skin inflammation associated with epidermal growth factor receptor-targeted therapy: an early and a late phase of papulopustular eruptions.
about
Risk of severe rash in cancer patients treated with EGFR tyrosine kinase inhibitors: a systematic review and meta-analysis.Dermatologic toxicities in epidermal growth factor receptor and multikinase inhibitors.Folliculitis induced by EGFR inhibitors, preventive and curative efficacy of tetracyclines in the management and incidence rates according to the type of EGFR inhibitor administered: a systematic literature review.Erlotinib-induced purpuric papulopustular eruption treated with pulsed azithromycin.A review of cutaneous toxicities from targeted therapies in the treatment of colorectal cancersCetuximab in non-melanoma skin cancer.Management of cutaneous adverse events induced by anti-EGFR (epidermal growth factor receptor): a French interdisciplinary therapeutic algorithm.Management of Dermatologic Complications of Lung Cancer Therapies.Review and Management of Acneiform Eruptions in Patients with Immune Disorders.Late epidermal growth factor receptor inhibitor-related papulopustular rash: a distinct clinical entity.Purpuric Drug Eruptions Caused by Epidermal Growth Factor Receptor Inhibitors for Non-Small Cell Lung Cancer: A Clinicopathologic Study of 32 Cases.Patient-reported symptoms and stepwise symptom management in patients on epidermal growth factor inhibitors: A retrospective, descriptive cohort study.Management of oral and gastrointestinal mucosal injury: ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-up.
P2860
Q30248499-675AA482-5744-428B-9C31-2951EF6BDADEQ33885559-1361CC59-5DA3-4518-B3BF-5067EC4D0A1DQ35913241-4FE6D837-61D8-4923-980D-2E56FCEBA0C7Q36986839-309872BD-BB1F-4500-A0F3-D67E4988391CQ37015703-36A40F5C-0DCD-4A01-AC0D-1C696108F8BDQ38004033-3AA5BDBA-88F4-4626-A99A-846F12D705FCQ38005946-4C903946-68E7-41D7-B1CB-6726D0183A99Q38580488-44F32BBD-6848-4EEE-B833-017884F5FBB6Q39155649-E5823104-15BA-4769-A143-344438F84DFCQ41244650-4DF54EAD-3E22-4BEE-9CD5-FAE863116B58Q47754320-83D19B04-2BD4-4D58-9956-AE564AD02954Q48287408-D3CF1548-415A-4A47-AA12-5941F32478D2Q53440587-F331ED75-8BD6-40D3-BA79-3F149411F187
P2860
Staphylococcus coagulase-positive skin inflammation associated with epidermal growth factor receptor-targeted therapy: an early and a late phase of papulopustular eruptions.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Staphylococcus coagulase-posit ...... e of papulopustular eruptions.
@ast
Staphylococcus coagulase-posit ...... e of papulopustular eruptions.
@en
type
label
Staphylococcus coagulase-posit ...... e of papulopustular eruptions.
@ast
Staphylococcus coagulase-posit ...... e of papulopustular eruptions.
@en
prefLabel
Staphylococcus coagulase-posit ...... e of papulopustular eruptions.
@ast
Staphylococcus coagulase-posit ...... e of papulopustular eruptions.
@en
P2093
P2860
P1433
P1476
Staphylococcus coagulase-posit ...... e of papulopustular eruptions.
@en
P2093
Iris Amitay-Laish
Michael David
Salomon M Stemmer
P2860
P304
P356
10.1634/THEONCOLOGIST.2010-0063
P577
2010-08-13T00:00:00Z